Skip to main content
Log in

The diagnostic performance of APC–PCI complex determination compared to d-dimer in the diagnosis of deep vein thrombosis

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

d-dimer testing is widely used as part of the diagnostic algorithm for the exclusion of deep vein thrombosis (DVT) but is considered of limited in value for ruling DVT in. Since d-dimers are poorly defined, there is no standardization of the assays and this makes reliable comparisons between clinical studies difficult. We report on a performance evaluation of a new marker of activated coagulation (Activated Protein-C in complex with Protein-C inhibitor, APC–PCI complex) compared to two quantitative d-dimer assays (Vidas®d-dimer Exclusion™and Autodimer®). The post-hoc comparison was made on 350 frozen plasma samples from consecutive outpatients suspected of DVT in a multicenter management study including clinical probability score, d-dimer testing, venous ultrasound and contrast venography as part of the diagnostic algorithm. Results: The APC–PCI complex performed inferior to the d-dimer assays in terms of sensitivity: 74 vs. >93%, negative predictive value: 91 vs. >96% and area under the curve: 0.82 vs. 0.9, but showed a significantly higher specificity: 80 vs. 40–60%. Specificity for the APC–PCI complex did not decrease with higher clinical probability score and the positive predictive value was significantly higher than that of the d-dimer assays in the intermediate/high probability cohort (66 vs. <52%). In this probability cohort, high levels of the APC–PCI complex and to a lesser extent, d-dimers, can give positive predictive values of >90% in up to 20% of the patients which indicates important clinical implications. However, for the exclusion of DVT at the pre-specified cut-off level, the APC–PCI complex perform inferior to the d-dimer assays in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Nordstrom M, Lindblad B, Bergqvist D, Kjallstrom T (1992) A prospective study of the incidence of of deep vein thrombosis within a defined urban population. J Intern Med 232:155–160

    Article  CAS  PubMed  Google Scholar 

  2. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O′Fallon WM, Melton LJ (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population–based study. Arch Intern Med 158:585–593

    Article  CAS  PubMed  Google Scholar 

  3. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J (2007) Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5:692–699

    Article  CAS  PubMed  Google Scholar 

  4. Hull R, Hirsch J (1981) Advances and controversies in the diagnosis, prevention, and treatment of venous thromboembolism. Prog haematol 12:73–123

    CAS  Google Scholar 

  5. Wells PS, Owen C, Doucette S, Fergusson D, Tran H (2006) Does this patient have deep vein thrombosis? Jama 295(2):199–207

    Article  CAS  PubMed  Google Scholar 

  6. Stein PD, Henry JW, Relyea B (1995) Untreated patients with pulmonary embolism: outcome, clinical, and laboratory assessment. Chest 107:931–935

    Article  CAS  PubMed  Google Scholar 

  7. Goldhaber SZ (1998) Pulmonary embolism. NEJM. 339:93–104

    Article  CAS  PubMed  Google Scholar 

  8. Coon WW, Willis PW III, Symons MJ (1969) Assessment of anticoagulant treatment of venous thromboembolism. Ann Surg 170:559–568

    Article  CAS  PubMed  Google Scholar 

  9. Hull R, Delmore T, Genton E (1979) Warfarin sodium versus low-dose heparin in the long term treatment of venous thrombosis. NEJM 301:855–858

    CAS  PubMed  Google Scholar 

  10. van der Meer FJ, Rosendaal FR, Vanderbroucke JP, Briet E (1993) Bleeding complications in oral antocoagulation therapy. An analysis of riskfactors. Arch Intern Med 153:1557–1562

    Article  PubMed  Google Scholar 

  11. Righini M, Perrier A, de Moerloose P, Bonamaeux H (2008) D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost 6:1059–1071

    Article  CAS  PubMed  Google Scholar 

  12. Goodacre S, Stevenson M, Wailoo A, Sampson F, Sutton AJ, Thomas S (2006) How should we diagnose deep-vein thrombosis? Q J Med 99:377–388

    CAS  Google Scholar 

  13. Stokes KR (1994) Complications of diagnostic venography. Sem Interv Radiol 11:102–106

    Article  Google Scholar 

  14. Morcos SK, Thomsen HS, Webb JAW (1999) Contrast media induced nephrotoxity: a consensus report. Eur Radiol 9:1602–1613

    Article  CAS  PubMed  Google Scholar 

  15. Bounamaeux H, de Moerloose P, Perrier A et al (1997) D-dimer testing in suspected venous thromboembolism: an update. QJM 90:437–442

    Article  Google Scholar 

  16. Perrier A, Desmarais S, Goehring C et al (1997) D-dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med 156:492–496

    CAS  PubMed  Google Scholar 

  17. Risch L, Monn A, Luthy R et al (2004) The predictive characteristics of D-dimer testing in outpatients with suspected venous thromboembolism. A Bayesian approach. Clin Chem Acta 345:79–87

    Article  CAS  Google Scholar 

  18. Tick LW, Nijkeuter M, Kramer MHH, Hovens MMC, Buller HR, Leebeek FWG, Huisman MV (2008) High D-dimers levels increase the likelihood of pulmonary embolism. J Intern Med 264:195–200

    Article  CAS  PubMed  Google Scholar 

  19. Stein PD, Hull RD (2004) D-dimer for the exclusion of acute deep vein thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 140(8):589–602

    PubMed  Google Scholar 

  20. Di Nisio M, Squizzato A, Rutjes AW, Buller HR, Zwinderman AH, Bossuyt PM (2007) Diagnostic accuracy of D-dimer tests for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost 5(2):296–304

    Article  CAS  PubMed  Google Scholar 

  21. Espana F, Vicente V, Scharrer I, Tabernero D, Griffin JH (1990) Determination of plasma protein C inhibitor and of two activated protein C inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease. Thromb Res 59:593–608

    Article  CAS  PubMed  Google Scholar 

  22. Minamikawa K, Wada H, Wakita Y et al (1994) Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism. Thromb Haemost 71:192–194

    CAS  PubMed  Google Scholar 

  23. Strandberg K, Astermark J, Björgell O, Becker C, Nilsson PE, Stenflo J (2001) Complexes between activated protein C and protein C inhibitor measured with a new method. Thromb Haemost 86:1400–1408

    CAS  PubMed  Google Scholar 

  24. Strandberg K, Kjellberg M, Knebel R, Lilja H, Stenflo J (2001) A sensitive immunochemical assay for measuring the concentration of the activated protein-Cprotein C inhibitor complex in plasma. Thromb Haemost 86:604–610

    CAS  PubMed  Google Scholar 

  25. Roumen-Klappe EM, den Heijer M, van Uum SH, van der Ven-Jongekrijg J, van der Graaf F, Wollersheim H (2002) Inflammatory response in acute phase of deep vein thrombosis. J Vasc Surg 35:701–706

    Article  PubMed  Google Scholar 

  26. Wells PS, Anderson DR, Bormanis J et al (1997) Value of assessment of pretest probability of deep vein thrombosis in clinical management. Lancet 350:1795–1798

    Article  CAS  PubMed  Google Scholar 

  27. Elf JL, Nilsson C, Strandberg K, Svensson PJ (2009) Clinical probability assessment and D-dimer determination in patients with suspected deep vein thrombosis, a prospective multicenter management study. Thromb Res 123:612–616

    Article  CAS  PubMed  Google Scholar 

  28. Strandberg K, Svensson A, Stenflo J (2003) Stabilyte tubes that contain strongly acidic citrate prevent in vitro complex formation between activated protein C and protein C inhibitor. Thromb Haemost 89:947–949

    PubMed  Google Scholar 

  29. Altman DG (1999) Practical statistics for medical research, First edn. Chapman and Hall, Florida

    Google Scholar 

  30. Nieuwenhuizen W, Emeis JJ, Vermond A (1982) Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats. Thromb Haemost 48:59–61

    CAS  PubMed  Google Scholar 

  31. Wells PS, Anderson DR, Rodger M et al (2003) Evaluation of D-dimer in the diagnosis of suspected deep vein thrombosis. NEJM 349:1227–1235

    Article  CAS  PubMed  Google Scholar 

  32. Le Gal G, Righini M, Parent F, van Strijen M, Coutraud F (2006) Diagnosis and management of subsegmental pulmonary embolism. J Thromb Haemost 4:724–731

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

We thank bioMerieux for providing the miniVidas device and the reagent. Substantial help in the statistical calculations has been provided by Håkan Lövkvist at the regional competence center for statistics, Skåne, Sweden.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Johan L. Elf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elf, J.L., Strandberg, K. & Svensson, P.J. The diagnostic performance of APC–PCI complex determination compared to d-dimer in the diagnosis of deep vein thrombosis. J Thromb Thrombolysis 29, 465–470 (2010). https://doi.org/10.1007/s11239-009-0426-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-009-0426-z

Keywords

Navigation